Delivery Order SPE2DB22D3301-SPE2DB24FY4MW
Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $127,208.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 60-count bottles of the generic drug valganciclovir 450 mg tablets. The order has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Valganciclovir 450 mg tablets, with a ceiling value of $2,585.74 and a completion date of July 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of 60 count bottles of the pharmaceutical product Valganciclovir 450 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $3,000.00 and a completion date of June 25, 2024. It is a Firm Fixed Price Delivery Order contract, with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Valganciclovir HCL 50 mg/ml in an 88ml unit, valued at $3,439.80 under firm fixed pricing. This delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The product will be delivered to...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,546.87, is for the supply of Valganciclovir 450 mg tablets over a period ending on June 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,662.65 firm fixed-price contract is for the delivery of 60 tablets of the medication valganciclovir 450 mg. The contract has a performance period through January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count packages) under a firm fixed-price contract valued at $4,031.70. This non-set-aside award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valganciclovir is an antiviral medication used to treat cytomegalovirus...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml (88 ml) on August 11, 2025, with a ceiling value of $1,024.62. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $2,354.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg valganciclovir tablets. Under this order, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the Defense Logistics...